Latest News

Pharmacists Can Incorporate the New Hypertension Guidelines Into Their Medication Therapy Management Practices

GLP-1 receptor agonists expand treatment options for diabetes, weight loss, and more, showing promise in heart failure, kidney disease, and neuroprotection.

Research funding disruptions at the National Institutes of Health (NIH) impact clinical trials, threatening treatment options for patients and highlighting the critical role of pharmacists in care continuity.

Sibeprenlimab offers a groundbreaking treatment for immunoglobulin A nephropathy, targeting APRIL to reduce kidney damage and improve patient outcomes.

Thunderstorms significantly increase asthma-related emergency visits, highlighting the need for storm-specific preparedness and management strategies for patients.

A new FDA-approved sublingual form of cyclobenzaprine HCl shows promising efficacy and tolerability in fibromyalgia.

New vaccine developments for Crimean-Congo hemorrhagic fever offer hope for prevention, highlighting pharmacists' crucial role in future vaccination efforts.

High-dose busulfan-melphalan enhances VRd therapy, improving progression-free survival in high-risk multiple myeloma patients undergoing ASCT.

Tech-Check-Tech Improves Workflow and Allows Pharmacists to Focus on Clinical Responsibilities

CAR T-cell therapy shows promise for treating HER2-positive breast cancer with CNS metastases, offering a novel approach to improve patient outcomes.

The FDA approved durvalumab with FLOT chemotherapy, revolutionizing treatment for early gastric and gastroesophageal junction cancers, enhancing survival rates.

New research reveals how age, lifestyle, and diabetes alter the gluteus maximus shape, highlighting sex-specific responses and metabolic health implications.

The FDA approves a reformulated ranitidine, addressing past safety concerns while treating GERD and peptic ulcers.

With this approval, Itvisma has become the first and only gene replacement therapy available for children aged 2 years and older, teenagers, and adults with SMA.

Understanding these medications is essential for their effective use.

Explore the complexities of dietary supplement regulation, the importance of third-party testing, and how pharmacists can guide safe usage.

A more significant association with cardiovascular disease (CVD) was observed among individuals with diabetes compared with those without.

The FDA approves ruxolitinib cream for treating atopic dermatitis in children, offering hope for millions affected by this chronic skin condition.

An Illinois Court Ruling Underscores How Intent and Knowledge Factor Into False Claims Act Liability for Pharmacy Reimbursement Submissions

Discover the stages of migraines and explore innovative treatments like Symbravo, designed to alleviate pain and improve quality of life.